Learn, Analyse & Invest
only with
Enrichmoney Orca logoEnrichmoney stock analysis page arrow image
+91
Download Orca
Orca app download play store imageOrca app download app store image
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Alivus Life Sciences Ltd.

Alivus Life Sciences

Alivus Life Sciences Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.

₹ 0.00

0.00 (0.00)%

EX-DatePurpose
10 11 2021 Quarterly Results
08 02 2022 Quarterly Results
20 04 2022 Audited Results & Final Dividend
04 08 2022 Quarterly Results
21 10 2022 Quarterly Results
27 01 2023 Quarterly Results
16 03 2023 Interim Dividend
27 04 2023 Audited Results
21 07 2023 Quarterly Results
09 10 2023 Interim Dividend
20 10 2023 Quarterly Results
23 01 2024 Quarterly Results
24 10 2024 Quarterly Results
23 01 2025 Quarterly Results
15 05 2025 Audited Results & Final Dividend
06 11 2025 Quarterly Results
22 01 2026 Quarterly Results
14 05 2026 Final Dividend & Audited Results
30 07 2026 Quarterly Results

News

19-AUG-2026

Alivus Life Sciences gets nod to acquire 76% stake in IQGEN-X Pharma

The Board of Directors of the company at its meeting held on August 18, 2026, approved the same

02:09 PM
28-JUL-2025

USFDA issues EIR with NAI classification for Alivus Life Sciences’ API unit

The USFDA had conducted an inspection from May 26, 2025 to May 30, 2025

11:53 AM
04-APR-2025

USFDA issues EIR with Voluntary Action Indicated status for Alivus Life Sciences’ API unit

The said API unit is located in GIDC Industrial Estate in the state of Gujarat

02:50 PM
03-APR-2025

Alivus Life Sciences inks pact with Torrent Urja 19

The company’s promoter company -- Nirma will acquire minimum 16.99% stake in Torrent Urja 19

02:12 PM
13-MAR-2024

Nirma acquires majority stake in Glenmark Life Sciences

This strategic acquisition marks a significant milestone for Nirma as it strengthens its presence in the pharmaceuticals and life sciences sector

12:09 PM
19-JAN-2024

Glenmark Life Sciences inks pact with Japanese innovator pharmaceutical company

The company will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator

10:40 AM
20-DEC-2023

CCI gives green signal for Nirma’s acquisition in Glenmark Life Sciences

In September this year, Glenmark Pharmaceuticals’ board had approved to divest 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma for Rs 5,651.5 crore

05:23 PM